Search

everythinglearnresearchcommunity

for

Search:↓

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Hair care products reduced hair roughness, a combination of Stemoxydine and Resveratrol increased hair density, fermented mackerel oil promoted hair growth, and genes TERT and Bmi-1 helped create new hair follicles.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Certain products and treatments can improve hair health and growth.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Human liver enzyme DHEA ST helps process minoxidil.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Fermented mackerel oil was found to promote hair growth by activating certain cell signals and increasing cell growth.

Mackerel fermented fish oil protects skin cells from damage by UVB light.

Hair care products used for 4 weeks made hair smoother.

The FDA rejected a testosterone drug again due to safety concerns.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Estrogen alone can lower testosterone in some transfeminine people.

The FDA did not approve a testosterone drug because of safety concerns.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Including androgens in hormone therapy may lower breast cancer risk.